<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sola Colom M</submitter><funding>European Research Council</funding><funding>Boehringer Ingelheim Fonds</funding><pagination>2198-2232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11148069</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(11)</volume><pubmed_abstract>Nuclear pore complex (NPC) biogenesis is a still enigmatic example of protein self-assembly. We now introduce several cross-reacting anti-Nup nanobodies for imaging intact nuclear pore complexes from frog to human. We also report a simplified assay that directly tracks postmitotic NPC assembly with added fluorophore-labeled anti-Nup nanobodies. During interphase, NPCs are inserted into a pre-existing nuclear envelope. Monitoring this process is challenging because newly assembled NPCs are indistinguishable from pre-existing ones. We overcame this problem by inserting Xenopus-derived NPCs into human nuclear envelopes and using frog-specific anti-Nup nanobodies for detection. We further asked whether anti-Nup nanobodies could serve as NPC assembly inhibitors. Using a selection strategy against conserved epitopes, we obtained anti-Nup93, Nup98, and Nup155 nanobodies that block Nup-Nup interfaces and arrest NPC assembly. We solved structures of nanobody-target complexes and identified roles for the Nup93 α-solenoid domain in recruiting Nup358 and the Nup214·88·62 complex, as well as for Nup155 and the Nup98 autoproteolytic domain in NPC scaffold assembly. The latter suggests a checkpoint linking pore formation to the assembly of the Nup98-dominated permeability barrier.</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>A checkpoint function for Nup98 in nuclear pore formation suggested by novel inhibitory nanobodies.</pubmed_title><pmcid>PMC11148069</pmcid><funding_grant_id>StuDySARCOMERE</funding_grant_id><pubmed_authors>Guttler T</pubmed_authors><pubmed_authors>Gorlich D</pubmed_authors><pubmed_authors>Gunkel P</pubmed_authors><pubmed_authors>Fu Z</pubmed_authors><pubmed_authors>Gregor K</pubmed_authors><pubmed_authors>Trakhanov S</pubmed_authors><pubmed_authors>Srinivasan V</pubmed_authors><pubmed_authors>Sola Colom M</pubmed_authors><pubmed_authors>Pleiner T</pubmed_authors></additional><is_claimable>false</is_claimable><name>A checkpoint function for Nup98 in nuclear pore formation suggested by novel inhibitory nanobodies.</name><description>Nuclear pore complex (NPC) biogenesis is a still enigmatic example of protein self-assembly. We now introduce several cross-reacting anti-Nup nanobodies for imaging intact nuclear pore complexes from frog to human. We also report a simplified assay that directly tracks postmitotic NPC assembly with added fluorophore-labeled anti-Nup nanobodies. During interphase, NPCs are inserted into a pre-existing nuclear envelope. Monitoring this process is challenging because newly assembled NPCs are indistinguishable from pre-existing ones. We overcame this problem by inserting Xenopus-derived NPCs into human nuclear envelopes and using frog-specific anti-Nup nanobodies for detection. We further asked whether anti-Nup nanobodies could serve as NPC assembly inhibitors. Using a selection strategy against conserved epitopes, we obtained anti-Nup93, Nup98, and Nup155 nanobodies that block Nup-Nup interfaces and arrest NPC assembly. We solved structures of nanobody-target complexes and identified roles for the Nup93 α-solenoid domain in recruiting Nup358 and the Nup214·88·62 complex, as well as for Nup155 and the Nup98 autoproteolytic domain in NPC scaffold assembly. The latter suggests a checkpoint linking pore formation to the assembly of the Nup98-dominated permeability barrier.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-06-02T08:28:49.09Z</modification><creation>2026-04-16T03:11:36.859Z</creation></dates><accession>S-EPMC11148069</accession><cross_references><pubmed>38649536</pubmed><doi>10.1038/s44318-024-00081-w</doi></cross_references></HashMap>